Pharmacological approaches to prion research

Biochemical Pharmacology

Volumn 63, Issue 8, 2002, Pages 1383-1388

  Supattapone, Surachai ^a   Nishina, Koren ^a   Rees, Judy R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Antibodies; Dendrimers; Pharmacology; Prion; Tetrapyrrole; Tricyclic

Indexed keywords

ACRIDINE DERIVATIVE; ANTIMALARIAL AGENT; CHLORPROMAZINE; CYSTEINE PROTEINASE INHIBITOR; MEPACRINE; PHENOTHIAZINE DERIVATIVE; PHTHALOCYANINE; POLYAMINE DERIVATIVE; PORPHYRIN DERIVATIVE; PRION INHIBITOR; PRION PROTEIN; PROTEIN INHIBITOR; PYRROLE DERIVATIVE; TRYPANOTHIONE; UNCLASSIFIED DRUG;

ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CELL CULTURE; CREUTZFELDT JAKOB DISEASE; CYTOLOGY; DRUG MECHANISM; HUMAN; KINETICS; MEDICAL RESEARCH; NONHUMAN; PHARMACOLOGICAL SCIENCE; PRION; PRION DISEASE; PRIORITY JOURNAL;

EID: 0037091006     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)00874-2     Document Type: Note

References (30)

1. Prions
2. Novel proteinaceous infectious particles cause scrapie
3. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain
4. A cellular gene encodes scrapie PrP 27-30 protein
5. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins
6. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein
7. Separation of scrapie prion infectivity from PrP amyloid polymers
8. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding
9. Opiate receptor: Demonstration in nervous tissue
10. Penicillin: Its basic site of action as an inhibitor of a peptide cross-linking reaction in cell wall mucopeptide synthesis
11. In search of a cure for CJD
12. Branched polyamines cure prion-infected neuroblastoma cells
13. Elimination of prions by branched polyamines and implications for therapeutics
14. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells
15. Cationic lipopolyamines induce degradation of PrPSc in scrapie-infected mouse neuroblastoma cells
16. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity
17. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody
18. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies
19. Mapping the prion protein using recombinant antibodies
20. Sc)-specific epitope defined by a monoclonal antibody
21. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform
22. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes
23. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells
24. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: A model for the scrapie species barrier
25. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155
26. Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation
27. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
28. Inhibition of Trypanosoma cruzi trypanothione reductase by acridines: Kinetic studies and structure-activity relationships
29. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines
30. Mimicking dominant negative inhibition of prion replication through structure-based drug design